☆ 4.6 Article

The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Hematology

Persistent endotheliopathy in the pathogenesis of long COVID syndrome: Comment from von Meijenfeldt et al.

Fien A. von Meijenfeldt et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Article Hematology

Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19

Malgorzata Wygrecka et al.

Summary: The altered levels of factor XII (FXII) and its activation products contribute to the high incidence of thrombotic events in COVID-19 patients. COVID-19 patients exhibit rapid consumption of FXII and no prolonged lag phase in fibrin formation triggered by the FXII activator kaolin, unlike patients with ARDS-influenza. Confocal and electron microscopy analysis show that COVID-19 patients form compact clots with thin fibers and small pores, leading to impaired clot lysis. Widespread compact fibrin deposits are observed in the lung tissue of COVID-19 patients.

BLOOD ADVANCES (2022)

添加到收藏夹

Article Medicine, General & Internal

Activation of the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients with SARS-CoV-2 Infection Could Contribute to COVID-19 Hypofibrinolytic State and Disease Severity Prognosis

Karen Claesen et al.

Summary: The changes in CPU and fibrinolytic antigen levels in COVID-19 patients may be associated with disease severity and duration of hospitalization.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Immunology

Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China

Pingzheng Mo et al.

Summary: This study aimed to clarify the characteristics of patients with refractory COVID-19, finding that these patients were older, more likely to be male, and had more underlying comorbid conditions. Patients with refractory disease required more aggressive treatments such as oxygen therapy and mechanical ventilation.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness

Fenghe Du et al.

Summary: This study discusses the association between thrombosis and inflammation in COVID-19 patients, as well as the pathological mechanisms involved. By examining the effects of cytokine release and ACE2 expression on promoting thrombosis, it provides some theoretical basis for the prevention and treatment of COVID-19.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

添加到收藏夹

Article Anesthesiology

Impaired fibrinolysis in critically ill COVID-19 patients

Mirjam Bachler et al.

Summary: Critically ill COVID-19 patients exhibit a hypercoagulable state with impaired fibrinolysis, characterized by increased clot firmness and decreased fibrinolytic response in whole blood coagulation tests. This hypofibrinolytic state may be at least partially due to a decreased fibrinolytic response.

BRITISH JOURNAL OF ANAESTHESIA (2021)

添加到收藏夹

Article Hematology

The ADAMTS13-von Willebrand factor axis in COVID-19 patients

Ilaria Mancini et al.

Summary: Severe COVID-19 patients exhibit an increased risk of thromboembolic events, with evidence of microthrombosis in the lungs of deceased patients. The study found a significant alteration of the VWF-ADAMTS13 axis in COVID-19 patients, with an elevated VWF:Ag to ADAMTS13 activity ratio strongly associated with disease severity, enhancing the hypercoagulable state and risk of microthrombosis in these patients.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Letter Hematology

Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study

Brandon Michael Henry et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients

Yu Zuo et al.

Summary: COVID-19 patients have elevated levels of tPA and PAI-1 in plasma, which are correlated with neutrophil counts and respiratory status. Particularly high levels of tPA are strongly associated with mortality and enhanced fibrinolysis, suggesting a subset of patients may have a favorable balance of factors for fibrinolysis. Further investigation into tPA as a biomarker is warranted.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Plasma Fibrinogen Independently Predicts Hypofibrinolysis in Severe COVID-19

Diana Schrick et al.

Summary: This pilot study explores the associations among platelet indices, conventional hemostasis parameters, and viscoelastometry data in severe COVID-19 patients. Patients with severe COVID-19 exhibited higher levels of inflammatory markers, hypercoagulability, and hypofibrinolysis, necessitating individualized thromboprophylaxis to prevent thrombotic complications.

METABOLITES (2021)

添加到收藏夹

Article Hematology

Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study

Ganeem K. Juneja et al.

Summary: Immunothrombosis and coagulopathy in the lung microvasculature may lead to lung injury and disease progression in COVID-19. Biomarkers such as elevated D-dimer were associated with disease severity, while clot lysis time, sTM, PAI-1, and plasminogen levels may have predictive ability for mortality.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Medicine, General & Internal

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani et al.

LANCET (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease

Gael B. Morrow et al.

Summary: PAI-1 plays a crucial role in maintaining hemostatic balance and is associated with cardiovascular diseases, inflammation, and metabolic syndrome.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

添加到收藏夹

Article Hematology

COVID-19-related laboratory coagulation findings

Katrien M. J. Devreese

Summary: The hemostatic balance in COVID-19 patients is significantly disrupted, leading to a high prothrombotic status. Elevated D-dimer levels are crucial in assessing the risk of thrombosis in these patients. Monitoring of heparin anticoagulant therapy is recommended using anti-Xa assay.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review

Chiara Agrati et al.

Summary: Severe COVID-19 cases present with blood clots and neutrophil-platelet aggregates, leading to an increased risk of cardiovascular complications and venous thrombotic events. The inflammatory storm may disrupt the interplay between platelets, endothelium, and leukocytes, contributing to COVID-19-associated coagulopathy. P-selectin is identified as a key molecule in this process and could potentially be used as a severity marker and therapeutic target for COVID-19 treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Cell Biology

Low level of plasminogen increases risk for mortality in COVID-19 patients

David Della-Morte et al.

Summary: This study found a significant association between low plasminogen levels and inflammatory markers, coagulation markers, and organ dysfunction markers in COVID-19 patients. Plasminogen may play a vital role in controlling the complex mechanisms behind the complications of COVID-19, serving as both a biomarker for prognosis and a potential therapeutic target.

CELL DEATH & DISEASE (2021)

添加到收藏夹

Article Critical Care Medicine

Platelet activation in critically ill COVID-19 patients

Nader Yatim et al.

Summary: This study found that elevated soluble P-selectin levels at admission were associated with COVID-19 severity and could predict intubation and death. Gene expression analysis indicated that critically ill patients had increased expression of genes related to platelet activation, with specific genes showing grade-dependent upregulation. ROC curve analysis identified PPBP/CXCL7 and SELPLG as biomarkers for intubation.

ANNALS OF INTENSIVE CARE (2021)

添加到收藏夹

Article Hematology

Comparison of the coagulopathies associated with COVID-19 and sepsis

Robert A. Campbell et al.

Summary: Patients with COVID-19 had significantly higher levels of D-dimer, EVTF activity, and active PAI-1 compared with healthy controls, while patients with sepsis had significantly higher levels of D-dimer and EVTF activity compared with healthy controls. High levels of both EVTF activity and active PAI-1 in COVID-19 patients may promote thrombosis due to simultaneous activation of coagulation and inhibition of fibrinolysis, and the high levels of active PAI-1 may explain the lower levels of D-dimer in COVID-19 patients compared with sepsis patients.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Immunology

Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

Aldo Bonaventura et al.

Summary: The authors suggest that SARS-CoV-2 infection induces a prothrombotic state and dysregulated immunothrombosis, leading to severe manifestations of COVID-19. They also discuss potential antithrombotic and immunomodulating drugs for treating COVID-19 patients, aiming to reduce the acute and long-term consequences of the disease by targeting immunothrombosis.

NATURE REVIEWS IMMUNOLOGY (2021)

添加到收藏夹

Article Hematology

Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality

Fien A. von Meijenfeldt et al.

Summary: The study found that COVID-19 patients with higher levels of respiratory support have significantly increased in vivo activation of coagulation and fibrinolysis, despite receiving anticoagulant therapy. Blood markers such as fibrinogen, von Willebrand factor, etc., also change with increasing levels of respiratory support.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Hematology

Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation

Gael B. Morrow et al.

HAEMATOLOGICA (2020)

添加到收藏夹

Article Hematology

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Ning Tang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Medicine, General & Internal

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Nanshan Chen et al.

LANCET (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

添加到收藏夹

Article Medicine, General & Internal

Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome Results From a Prospective, Single-Center, Clinicopathologic Case Series

Sigurd F. Lax et al.

ANNALS OF INTERNAL MEDICINE (2020)

添加到收藏夹

Letter Respiratory System

Pulmonary embolism in patients with COVID-19 pneumonia

Florian Bompard et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Article Virology

Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19

Yong Gao et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

添加到收藏夹

Article Hematology

High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients

Jean-Francois Llitjos et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Review Hematology

Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19

Claire S. Whyte et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Letter Hematology

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19

Marisa Dolhnikoff et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

添加到收藏夹

Review Hematology

Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis

Florian Langer et al.

HAMOSTASEOLOGIE (2020)

添加到收藏夹

Letter Medicine, General & Internal

Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients

Mario Bazzan et al.

INTERNAL AND EMERGENCY MEDICINE (2020)

添加到收藏夹

Article Hematology

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

George Goshua et al.

LANCET HAEMATOLOGY (2020)

添加到收藏夹

Review Cell Biology

Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts

Jin Wang et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2020)

添加到收藏夹

Article Hematology

A new pedigree with thrombomodulin-associated coagulopathy in which delayed fibrinolysis is partially attenuated by co-inherited TAFI deficiency

Sarah K. Westbury et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Hematology

Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis

Christophe Nougier et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Hematology

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

F. A. Klok et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Letter Hematology

Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis

Setor K. Kunutsor et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Article Hematology

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

Corrado Lodigiani et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Review Cell Biology

The coagulopathy, endotheliopathy, and vasculitis of COVID-19

Toshiaki Iba et al.

INFLAMMATION RESEARCH (2020)

添加到收藏夹

Article Pathology

COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City

Alain C. Borczuk et al.

MODERN PATHOLOGY (2020)

添加到收藏夹

Article Hematology

Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation

Toshiaki Iba et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Leptin as a predictive marker for metabolic syndrome

Abhijit A. Ghadge et al.

CYTOKINE (2019)

添加到收藏夹

Article Engineering, Biomedical

DiameterJ: A validated open source nanofiber diameter measurement tool

Nathan A. Hotaling et al.

BIOMATERIALS (2015)

添加到收藏夹

Article Genetics & Heredity

Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross

Lisa E. Gralinski et al.

PLOS GENETICS (2015)

添加到收藏夹

Review Hematology

Fibrin Clot Structure and Function A Role in the Pathophysiology of Arterial and Venous Thromboembolic Diseases

Anetta Undas et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

IL-8 induces imbalances between nitric oxide and endothelin-1, and also between plasminogen activator inhibitor-1 and tissue-type plasminogen activator in cultured endothelial cells

Min Cheng et al.

CYTOKINE (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-β signaling

Xingang Zhao et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

添加到收藏夹

Article Oncology

Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients:: relation to the acute lung injury and pathogenesis of SARS

L. He et al.

JOURNAL OF PATHOLOGY (2006)

添加到收藏夹

Article Hematology

Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI

NJ Mutch et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)

添加到收藏夹

Article Physiology

Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury

P Prabhakaran et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Thrombolysis: Newer thrombolytic agents and their role in clinical medicine

TK Nordt et al.

HEART (2003)

添加到收藏夹

Article Biochemistry & Molecular Biology

Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin

TJ Podor et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.